Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab

被引：0
|
作者：
S Sivaprasad
E Pearce
V Chong
机构：
[1] Laser and Retinal Research Unit,Department of Ophthalmology
[2] King's College Hospital,undefined
[3] Oxford West Wing,undefined
[4] The John Radcliffe Hospital,undefined
来源：
Eye | 2011年 / 25卷
关键词：
fixation stability; antiVEGF; neovascular age-related macular degeneration; microperimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1612 / 1616
页数：4
相关论文
共 50 条
  • [21] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [22] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
  • [23] Implementation studies of ranibizumab for neovascular age-related macular degeneration
    Bloch, Sara Brandi
    ACTA OPHTHALMOLOGICA, 2014, 92 (01) : 98 - 98
  • [24] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [25] Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration
    Patel, Ravi D.
    Momi, Rominder S.
    Hariprasad, Seenu M.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (06) : 372 - 379
  • [26] Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.
    Folk, James C.
    Stone, Edwin M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (17): : 1648 - 1655
  • [27] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [28] Implementation studies of ranibizumab for neovascular age-related macular degeneration
    Bloch, Sara Brandi
    ACTA OPHTHALMOLOGICA, 2013, 91 : 1 - 22
  • [29] Therapeutic effects of ranibizumab in neovascular age-related macular degeneration
    Ciulla, Thomas A.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 679 - 693
  • [30] Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    Brown, David M.
    Kaiser, Peter K.
    Michels, Mark
    Soubrane, Gisele
    Heier, Jeffrey S.
    Kim, Robert Y.
    Sy, Judy P.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1432 - 1444
12345